Not Signed In - Stereotaxis Announces Clearance Of Stereotaxis System For Use In Neurovascular And Peripheral Applications
Tue, 07 Nov 2006 08:00 AM EST
... Stereotaxis, Inc. (Nasdaq: STXS) today announced 510(k) FDA clearance of the Niobe(R) magnetic navigation system for use in neurovascular and peripheral applications with the Company's family of Cronus(R) magnetically enabled .014" vascular guidewires. [click link for full article] ...
Related Topics
- Creatinine Clearance
- Peripheral Neuropathy
- Immune System
- Digestive System
- Endocrine System
- Peripheral Vascular Disease
- Health System
- Creatinine
- Vascular Disease
- Neuropathy
- Peripheral Blood Stem Cells
- Peripheral Nerve Disorders
- Lymphatic Diseases
- Neurological Diseases And Disorders
- Surveillance
- Peripheral emboli
- Peripheral Vascular Diseases
- Peripheral arterial disease
- Health Care Delivery
- Loss of function of peripheral nerves, ataxia
email this page
print this page
bookmark this page
feedback on this page
